CALM2
Calmodulin-2
Also known as: CALM2_HUMAN, CAMII, PHKD, PHKD2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DP24
- Gene
- CALM2
- Ensembl
- ENSG00000143933
- Chromosome
- 2
- Canonical length
- 149 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins
OverviewNCBI Gene
This gene is a member of the calmodulin gene family. There are three distinct calmodulin genes dispersed throughout the genome that encode the identical protein, but differ at the nucleotide level. Calmodulin is a calcium binding protein that plays a role in signaling pathways, cell cycle progression and proliferation. Several infants with severe forms of long-QT syndrome (LQTS) who displayed life-threatening ventricular arrhythmias together with delayed neurodevelopment and epilepsy were found to have mutations in either this gene or another member of the calmodulin gene family (PMID:23388215). Mutations in this gene have also been identified in patients with less severe forms of LQTS (PMID:24917665), while mutations in another calmodulin gene family member have been associated with catecholaminergic polymorphic ventricular tachycardia (CPVT)(PMID:23040497), a rare disorder thought to be the cause of a significant fraction of sudden cardiac deaths in young individuals. Pseudogenes of this gene are found on chromosomes 10, 13, and 17. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
Canonical amino-acid sequenceUniProt
149 residues, UniProt reviewed canonical sequence.
>P0DP24|CALM2
1 MADQLTEEQI AEFKEAFSLF DKDGDGTITT KELGTVMRSL GQNPTEAELQ DMINEVDADG
61 NGTIDFPEFL TMMARKMKDT DSEEEIREAF RVFDKDGNGY ISAAELRHVM TNLGEKLTDE
121 EVDEMIREAD IDGDGQVNYE EFVQMMTAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CALM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 1,306 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 1,306 nTPM
- amygdala: 1,267 nTPM
- spinal cord: 1,255 nTPM
- cerebral cortex: 1,194 nTPM
- midbrain: 1,157 nTPM
- basal ganglia: 1,079 nTPM
Single-cell type
- fallopian tube ciliated cells: 429 nCPM
- fallopian secretory cells: 267 nCPM
- late primary spermatocytes: 266 nCPM
- early spermatids: 230 nCPM
- epididymal efferent duct ciliated cells: 224 nCPM
- neutrophils: 197 nCPM
Immune cell
- basophil: 950 nTPM
- intermediate monocyte: 847 nTPM
- eosinophil: 780 nTPM
- non-classical monocyte: 766 nTPM
- total PBMC: 498 nTPM
- classical monocyte: 450 nTPM
Brain region
- white matter: 1,166 nTPM
- cerebral cortex: 911 nTPM
- thalamus: 875 nTPM
- cerebellum: 821 nTPM
- hippocampal formation: 816 nTPM
- pons: 810 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CALM2.
Disease | AllUniProt
Conditions CALM2 is implicated in, by any mechanism.
- Long QT syndrome 15 (LQT15) MIM:616249
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 235 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Long QT syndrome 1
- Long QT syndrome 15
- Cardiovascular phenotype
- Long QT syndrome
- SUDDEN INFANT DEATH SYNDROME
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 2.79
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcineurin-mediated signaling
- detection of calcium ion
- G protein-coupled receptor signaling pathway
- G2/M transition of mitotic cell cycle
- long-term synaptic potentiation
- negative regulation of calcium ion export across plasma membrane
- negative regulation of ryanodine-sensitive calcium-release channel activity
- presynaptic endocytosis
- regulation of calcium-mediated signaling
- regulation of cardiac muscle contraction
- regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- regulation of cell communication by electrical coupling involved in cardiac conduction
- regulation of cytokinesis
- regulation of heart rate
- regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- response to calcium ion
- substantia nigra development
Molecular functions
- adenylate cyclase activator activity
- adenylate cyclase binding
- calcium channel inhibitor activity
- calcium channel regulator activity
- calcium ion binding
- calcium-dependent protein binding
- protein kinase binding
- protein phosphatase activator activity
- protein serine/threonine kinase activator activity
- titin binding
- transmembrane transporter binding
- transporter inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CALM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CALM2 as an antibody target. Whether an autoantibody or antibody against CALM2 could matter depends on whether native CALM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CALM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CALM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...